Lawood & Co’s Abbott ABT Stock Holding History

Lawood & Co’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,650	Closed	-$332K	–	91
2025 Q4	$332K	Buy	+2,650	New	+$338K	0.31%	71

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Lawood & Co's ABT Position: Q1 2026 in Review

Lawood & Co sold out of Abbott (ABT) in Q1 2026, closing a stake of 2,650 shares — an estimated $332K sold.

Lawood & Co first reported a position in ABT in Q4 2025 and held it in 1 quarter. The position peaked at $332K in Q4 2025. 3,106 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

Lawood & Co reported no remaining Abbott position as of Q1 2026 after selling out during the quarter.
Lawood & Co sold 2,650 Abbott shares in Q1 2026, an estimated $332K.
Lawood & Co first reported a position in Abbott in Q4 2025 and held it in 1 quarter.
Lawood & Co's Abbott position peaked at $332K in Q4 2025.
3,106 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Lawood & Co's 13F filing for Q1 2026, filed 14 Apr 2026.